Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell

Xiaoyan Xu1, Beiying Liu, Pengcheng Zou

  • 1Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, P.R. China; Department of Pathology, School of Basic Medical Sciences, Inner Monglia Medical College, Huhhot, 010059, P.R. China; Department of Pathology, The Affiliated Hospital of Inner Monglia Medical College, Huhhot, 010059, P.R. China.

Insights

Silencing the LASS2/TMSG1 gene in prostate cancer cells boosts Vacuolar H(+) ATPase activity, promoting cell invasion and metastasis. This finding highlights LASS2/TMSG1 as a potential therapeutic target for advanced prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Longevity assurance homolog 2 of yeast LAG1 (LASS2), also known as tumor metastasis suppressor gene 1 (TMSG1), has unclear antitumor mechanisms.
  • LASS2/TMSG1 interacts with the C subunit of Vacuolar H(+) ATPase (V-ATPase), suggesting a role in regulating cell invasion and metastasis.

Purpose of the Study:

  • To investigate the effect of LASS2/TMSG1 gene silencing on prostate carcinoma cell invasion and metastasis.
  • To explore the functional interaction between LASS2/TMSG1 and V-ATPase in prostate cancer.

Main Methods:

  • Utilized small hairpin RNA (shRNA) to silence LASS2/TMSG1 in the human prostate carcinoma cell line PC-3M-2B4.
  • Assessed V-ATPase activity, extracellular hydrogen ion concentration, and matrix metalloproteinase (MMP) activation.
  • Evaluated cell proliferation, survival, and invasion in vitro, and tumor growth and lymph node metastasis in vivo.

Main Results:

  • Silencing LASS2/TMSG1 significantly increased V-ATPase activity and extracellular acidity.
  • This led to enhanced activation of secreted MMP-2 and MMP-9, promoting cell proliferation, survival, and invasion.
  • In vivo studies showed accelerated prostate cancer growth and lymph node metastasis upon LASS2/TMSG1 silencing.

Conclusions:

  • Silencing LASS2/TMSG1 enhances prostate cancer invasion and metastasis by increasing V-ATPase activity.
  • LASS2/TMSG1 acts as a suppressor of invasion and metastasis in prostate cancer.
  • LASS2/TMSG1 represents a promising therapeutic target for advanced prostate cancer.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K